[go: up one dir, main page]

HUP9700927A2 - Fluorozott D3-vitamin analógok és ezeket tartalmazó gyógyszerkészítmények - Google Patents

Fluorozott D3-vitamin analógok és ezeket tartalmazó gyógyszerkészítmények

Info

Publication number
HUP9700927A2
HUP9700927A2 HU9700927A HUP9700927A HUP9700927A2 HU P9700927 A2 HUP9700927 A2 HU P9700927A2 HU 9700927 A HU9700927 A HU 9700927A HU P9700927 A HUP9700927 A HU P9700927A HU P9700927 A2 HUP9700927 A2 HU P9700927A2
Authority
HU
Hungary
Prior art keywords
vitamine
analogues
fluorinated
pharmaceutical compositions
compositions containing
Prior art date
Application number
HU9700927A
Other languages
English (en)
Inventor
Bernard Michael Hennessy
Milan Radoje Uskokovic
Original Assignee
F.Hoffmann-La Roche Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F.Hoffmann-La Roche Ag. filed Critical F.Hoffmann-La Roche Ag.
Publication of HU9700927D0 publication Critical patent/HU9700927D0/hu
Publication of HUP9700927A2 publication Critical patent/HUP9700927A2/hu
Publication of HUP9700927A3 publication Critical patent/HUP9700927A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Az (I) általánős képletű vegyületek -(mely képletbenRjelentése hidrőgénatőm, flűőratőm vagy hidrőxilcsőpőrt ésX jelentése =CH2 vagy haRjelentése hidrőxilcsőpőrt, úgy X jelentése hidrőgénatőm vagy=CH2) -, melyekhiperbűrjánzásős rendellenességek, neőpláziás betegségek és feggyúmi-rigy-betegségek kezelésére alkalmazhatók.ŕ
HU9700927A 1996-05-23 1997-05-21 Fluorinated vitamine d3 analogues and pharmaceutical compositions containing them HUP9700927A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1818796P 1996-05-23 1996-05-23

Publications (3)

Publication Number Publication Date
HU9700927D0 HU9700927D0 (en) 1997-07-28
HUP9700927A2 true HUP9700927A2 (hu) 1998-01-28
HUP9700927A3 HUP9700927A3 (en) 1999-07-28

Family

ID=21786696

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9700927A HUP9700927A3 (en) 1996-05-23 1997-05-21 Fluorinated vitamine d3 analogues and pharmaceutical compositions containing them

Country Status (30)

Country Link
US (1) US5888994A (hu)
EP (1) EP0808831B1 (hu)
JP (1) JP2858571B2 (hu)
KR (1) KR100237523B1 (hu)
CN (1) CN1081184C (hu)
AR (1) AR007240A1 (hu)
AT (1) ATE195514T1 (hu)
AU (1) AU720098B2 (hu)
BR (1) BR9703373A (hu)
CA (1) CA2204478C (hu)
CO (1) CO4840512A1 (hu)
CZ (1) CZ157997A3 (hu)
DE (1) DE69702812T2 (hu)
DK (1) DK0808831T3 (hu)
ES (1) ES2150719T3 (hu)
GR (1) GR3034832T3 (hu)
HR (1) HRP970274A2 (hu)
HU (1) HUP9700927A3 (hu)
IL (1) IL120842A0 (hu)
MA (1) MA24345A1 (hu)
NO (1) NO971934L (hu)
NZ (1) NZ314838A (hu)
PL (1) PL320131A1 (hu)
PT (1) PT808831E (hu)
SG (1) SG50831A1 (hu)
TR (1) TR199700418A3 (hu)
TW (1) TW374762B (hu)
UY (1) UY24563A1 (hu)
YU (1) YU19997A (hu)
ZA (1) ZA974334B (hu)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO971934L (no) * 1996-05-23 1997-11-24 Hoffmann La Roche Flourinerte vitamin D3 -analoger
JP2002506429A (ja) * 1997-05-16 2002-02-26 ウィメン アンド インファンツ ホスピタル ３−エピビタミンｄ２化合物及びその使用法
JP2002505668A (ja) 1997-05-16 2002-02-19 ウィメン アンド インファンツ ホスピタル 環状エーテルビタミンＤ３化合物、１α（ＯＨ）３−エピ−ビタミンＤ３化合物及びそれらの使用法
EP1015423B1 (en) * 1997-09-08 2003-05-02 F. Hoffmann-La Roche Ag 1,3-dihydroxy-20,20-dialkyl-vitamin d 3? analogs
AU3390400A (en) * 1999-03-05 2000-09-21 Johns Hopkins University, The Regulating skin appearance and composition with a fluorinated vitamin d3 analog compound
US7148211B2 (en) * 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
WO2006051106A1 (en) 2004-11-12 2006-05-18 Bioxell Spa Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer
PT3095447T (pt) 2006-02-03 2022-01-24 Opko Renal Llc Tratamento da insuficiência e deficiência de vitamina d com 25-hidroxivitamina d2 e 25-hidroxivitamina d3
SI2037936T1 (sl) 2006-06-21 2014-11-28 Opko Renal, Llc Postopek zdravljenja in prepreäśevanja sekundarnega hiperparatiroidizma
EP2148684B1 (en) 2007-04-25 2013-01-16 Cytochroma Inc. Method of treating vitamin d insufficiency and deficiency
SI2481400T1 (sl) 2007-04-25 2014-11-28 Opko IP Holdings II, Inc. Nadzorovano oralno sproščanje sestavkov, ki vsebujejo spojino vitamina D in voskasti nosilec
LT2552484T (lt) 2010-03-29 2020-04-27 Opko Ireland Global Holdings, Ltd. Būdai ir kompozicijos, skirti paratiroidų lygiams sumažinti
US8754067B2 (en) 2010-11-12 2014-06-17 Wisconsin Alumni Research Foundation 22-haloacetoxy-homopregnacalciferol analogs and their uses
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
MY198547A (en) 2016-03-28 2023-09-04 Opko Ireland Global Holdings Ltd Methods of vitamin d treatment

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5039671A (en) * 1984-12-19 1991-08-13 Hoffmann-La Roche Inc. Trifluorinated-1α,25S-dihydroxy vitamin D3 compounds
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
US5145846A (en) * 1988-01-20 1992-09-08 Hoffmann-La Roche Inc. Vitamin D3 analogs
GB9007236D0 (en) * 1990-03-30 1990-05-30 Leo Pharm Prod Ltd Chemical compounds
GB9017890D0 (en) * 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
US5206230A (en) * 1991-06-05 1993-04-27 Daikin Industries, Ltd. Fluorine-containing vitamin D3 analogues and pharmaceutical composition containing the same
US5210237A (en) * 1991-08-27 1993-05-11 Daikin Industries, Ltd. Vitamin d3 analogues
US5200536A (en) * 1992-02-10 1993-04-06 Daikin Industries Ltd. Fluorine-containing vitamin D3 analogues
GB9206648D0 (en) * 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
ES2091515T3 (es) * 1992-05-20 1996-11-01 Hoffmann La Roche Analogos fluorados de la vitamina d3.
CA2096105A1 (en) * 1992-10-07 1994-04-08 Enrico Giuseppe Baggiolini (Deceased) Vitamin d3 fluorinated analogs
TW267161B (hu) * 1992-11-20 1996-01-01 Hoffmann La Roche
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
US5384314B1 (en) * 1994-03-11 1997-08-05 Hoffmann La Roche 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol
NO971934L (no) * 1996-05-23 1997-11-24 Hoffmann La Roche Flourinerte vitamin D3 -analoger

Also Published As

Publication number Publication date
IL120842A0 (en) 1997-09-30
UY24563A1 (es) 2000-12-29
SG50831A1 (en) 1998-07-20
DE69702812D1 (de) 2000-09-21
GR3034832T3 (en) 2001-02-28
DK0808831T3 (da) 2001-01-02
ES2150719T3 (es) 2000-12-01
NO971934D0 (no) 1997-04-25
TR199700418A2 (xx) 1997-12-21
MX9703776A (es) 1998-06-30
CA2204478C (en) 2006-11-21
ATE195514T1 (de) 2000-09-15
CA2204478A1 (en) 1997-11-23
JPH1045712A (ja) 1998-02-17
PL320131A1 (en) 1997-11-24
MA24345A1 (fr) 1998-07-01
EP0808831A2 (en) 1997-11-26
HU9700927D0 (en) 1997-07-28
BR9703373A (pt) 1998-09-15
AR007240A1 (es) 1999-10-27
TW374762B (en) 1999-11-21
KR970074763A (ko) 1997-12-10
NZ314838A (en) 1998-01-26
AU2357297A (en) 1997-11-27
ZA974334B (en) 1997-11-24
YU19997A (sh) 1999-07-28
KR100237523B1 (ko) 2000-01-15
TR199700418A3 (tr) 1997-12-21
EP0808831A3 (en) 1999-02-03
US5888994A (en) 1999-03-30
CZ157997A3 (en) 1997-12-17
HUP9700927A3 (en) 1999-07-28
DE69702812T2 (de) 2001-01-25
JP2858571B2 (ja) 1999-02-17
AU720098B2 (en) 2000-05-25
CN1169425A (zh) 1998-01-07
PT808831E (pt) 2000-12-29
HRP970274A2 (en) 1998-04-30
NO971934L (no) 1997-11-24
CO4840512A1 (es) 1999-09-27
EP0808831B1 (en) 2000-08-16
CN1081184C (zh) 2002-03-20

Similar Documents

Publication Publication Date Title
HUP9700927A2 (hu) Fluorozott D3-vitamin analógok és ezeket tartalmazó gyógyszerkészítmények
HUP9700926A2 (hu) D3-vitamin-analógok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
GR3031659T3 (en) Enniatines and enniatine derivates used to control endoparasites.
BR9916132A (pt) Composições e utilização das mesmas
YU47204B (sh) Derivati didehidro-vitamina d3
DE69501591D1 (de) Lactobazillusstämme menschlichen ursprungs, ihre zusammensetzung und deren verwendung
DE19875032I2 (de) Mometason-Furoate-Monohydrat, Verfahren zu seiner Herstellung und das enthaltende pharmazeutische Zusammensetzungen
ES2061252T3 (es) Agente antitusivo y regulador de la mucosa, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
TR200002218T2 (tr) 2-(Pürin-9-il)-Tetrahidrofüran -3,4-Diol türevleri
SE8700499D0 (sv) Novel pharmacologically active compounds
PL330763A1 (en) Insulin preparations containing nacl
BRPI0408655A (pt) formulações compreendendo um agente ativo e cacau em pó e a sua utilização
PL314187A1 (en) Novel derivatives of pyrazine carboxamide, method of obtaining them and their application in pharmaceutical composition
ATE272628T1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
MX9704037A (es) 1,1-dioxidos de 1,2,5-tiadiazolidin-3-ona 2-substituida y composiciones y metodo de uso de los mismos.
DE69729183T2 (de) Als entzündungshemmende mittel nützliche dihydrobenzofurane und verwandte verbindungen
HUP0000377A2 (hu) Amin-hidrofluoridok és felhasználásuk szájápoló szerként
ATE141914T1 (de) Fluorierte analoge vitamins d3
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
HUP9700609A2 (hu) 1,25-Dihidroxi-16,22,23-triszdehidro-kolekalciferol-származékok, ezeket tartalmazó gyógyszerkészítmények és intermedierek
DE69614552D1 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
IL67400A0 (en) 3,7alpha-diazacyclohepta(j,k)fluorene derivatives,their preparation and pharmaceutical compositions containing them
UA41114A (uk) Спосіб прогнозування ступеня ризику виникнення професійних пилових захворювань
ECSP972130A (es) Analogos de vitamina d3 - fluorinados
IT9048031A0 (it) 6 fluoro 6 metilpregn-4-ene-3,20 dioni e 6-fluoro-6-metilpregna-l, 4-diene-3,20-dioni,procedimento per la loro preparazione e composizioni farmaceutiche ad attivita' anti-infiammatoria che li contengono